Change search criteria ↓

Search results

1 183 projects found matching your search criteria:

  1. 151. Strategies to improve the efficacy of NK cells in targeting aggressive B-cell lymphomas

    Principal investigator: dr Małgorzata Bobrowicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: WEAVE-UNISONO, Panel: NZ6

  2. 152. The role of free fatty acid receptors in pathophysiology of the functional gastrointestinal tract disorders: new therapi…

    Principal investigator: dr hab. Maciej Stanisław Sałaga

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM BIS 5, Panel: NZ7

  3. 153. Search for novel IKK-β inhibitors in the context of diseases with neuroinflammatory origin – structure-based drug design…

    Principal investigator: Emilia Aleksandra Sługocka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  4. 154. Endothelial bioenergetics as a novel target for vascular protection – unveiling the mitochondrial mechanisms of lipid-lo…

    Principal investigator: dr Alicja Małgorzata Braczko

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 22, Panel: NZ5

  5. 155. Myeloid cell subpopulations as a source of effector cells for anticancer therapies using CAR chimeric receptors

    Principal investigator: dr hab. Angelika Muchowicz

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 25, Panel: NZ6

  6. 156. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for …

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

    Call: OPUS 25, Panel: NZ6

  7. 157. Specific immune signatures of T cells as biomarkers of the post-COVID Syndrome and predictors of long-term health dysfun…

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM BIS 4, Panel: NZ6

  8. 158. Gaining control on XBP1s signaling as a starting point for novel cancer therapies

    Principal investigator: prof. Rafał Artur Bartoszewski

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 24, Panel: NZ7

  9. 159. Design and implementation of effective cOmbination of Phages and Antibiotics for improved TheRApy protocols against KLEb…

    Principal investigator: prof. Zuzanna - Drulis-Kawa

    Uniwersytet Wrocławski, Wydział Nauk Biologicznych

    Call: JPIAMR ACTION Call 2022, Panel: NZ6

  10. 160. Histone demethylase inhibitors as chemosensitivity modulators in the treatment of head and neck squamous cell carcinoma

    Principal investigator: Dawid Dariusz Dorna

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 21, Panel: NZ7

  11. 161. Crystallographic analysis of RNA-ligand complexes. Towards rational design oflead compounds for development of therapies…

    Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 23, Panel: NZ7

  12. 162. Anti-inflammatory effect of senotherapeutic agents on gingival fibroblasts as a potential therapy for periodontitis

    Principal investigator: Alicja Danuta Płonczyńska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: PRELUDIUM 21, Panel: NZ5

  13. 163. New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychi…

    Principal investigator: prof. Krzysztof Tomasz Kamiński

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 23, Panel: NZ7

  14. 164. Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular st…

    Principal investigator: dr Bartłomiej Pochwat

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  15. 165. Targeting UDP-glucose and P2Y14 receptor interaction for therapeutic modulation of inflammatory lung diseases

    Principal investigator: dr Tadeusz Piotr Karcz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  16. 166. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a…

    Principal investigator: dr hab. Dorota Justyna Łażewska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  17. 167. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  18. 168. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  19. 169. Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

    Principal investigator: dr Anna Piotrowska-Murzyn

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ5

  20. 170. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy…

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 3, Panel: NZ7

  21. 171. Investigation of the MLK4 biology in breast cancer and search for new therapeutic strategies using innovative PROTAC com…

    Principal investigator: dr Anna Agnieszka Marusiak

    Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

    Call: SONATA BIS 11, Panel: NZ5

  22. 172. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized…

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  23. 173. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  24. 174. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent…

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 20, Panel: NZ7

  25. 175. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil…

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 20, Panel: NZ7

  26. 176. Normalization of energy metabolism as a way to develop innovative antithrombotic therapies

    Principal investigator: dr Patrycja Kaczara

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: OPUS 21, Panel: NZ7

  27. 177. Addressing the brain glioma temozolomide therapy limitations

    Principal investigator: dr hab. Joanna Małgorzata Lewandowska-Łańcucka

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 21, Panel: NZ7

  28. 178. Mechanisms involved in heme acquisition - potential targets for therapies directed towards reduction of Porphyromonas gi…

    Principal investigator: dr Michał Sylwester Śmiga

    Uniwersytet Wrocławski, Wydział Biotechnologii

    Call: OPUS 21, Panel: NZ6

  29. 179. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  30. 180. Supporting a therapy of non-healing wounds with witch hazel bark

    Principal investigator: Karolina Anna Pawłowska

    Warszawski Uniwersytet Medyczny

    Call: PRELUDIUM 20, Panel: NZ7

  31. 181. Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha…

    Principal investigator: dr Dawid Marcin Panek

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  32. 182. Aging-associated, specific pathomechanisms of endothelial dysfunction in sepsis: pathway analysis and experimental thera…

    Principal investigator: prof. Stefan Karol Chłopicki

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: WEAVE-UNISONO, Panel: NZ7

  33. 183. MicroRNAome maturation control and its application in selective targeting of cancer stem cells

    Principal investigator: dr Jakub Godlewski

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 20, Panel: NZ5

  34. 184. Identification of the interdependence between SWI/SNF-type chromatin remodeling complex, metabolism control and RNA modi…

    Principal investigator: prof. Tomasz Jacek Sarnowski

    Instytut Biochemii i Biofizyki PAN

    Call: OPUS 20, Panel: NZ5

  35. 185. Identification of surface proteins as alternate targets for CAR-T therapy against CD19-negative tumors.

    Principal investigator: dr hab. Magdalena Hanna Winiarska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM BIS 2, Panel: NZ6

  36. 186. Targeting deregulated expression of anti-apoptotic proteins belonging to the Bcl-2 family in macrophages as a potential …

    Principal investigator: dr Maja Anna Sochalska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

    Call: SONATA 16, Panel: NZ5

  37. 187. New therapies of opioid use disorder

    Principal investigator: dr Wojciech Barnaba Solecki

    Uniwersytet Jagielloński, Wydział Zarządzania i Komunikacji Społecznej

    Call: OPUS 20, Panel: NZ7

  38. 188. Prenatal exposure to glucocorticoids as a risk factor for depression - the importance of epigenetic mechanisms in the br…

    Principal investigator: dr Katarzyna Elżbieta Głombik

    Instytut Farmakologii PAN

    Call: SONATA 16, Panel: NZ7

  39. 189. Long noncoding RNA - new aim of anti-influenza therapy

    Principal investigator: dr Marta Soszyńska-Jóźwiak

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 16, Panel: NZ6

  40. 190. Immunogenicity of plant-produced chimeric Virus-Like Particles formed byHBcAg displaying HBsAg epitopes for potential th…

    Principal investigator: dr Benita Ortega Berlanga

    Instytut Genetyki Roślin PAN

    Call: POLS, Panel: NZ7

  41. 191. Understanding of human insulin maturation for cell and gene therapy in diabetes

    Principal investigator: dr hab. Małgorzata Borowiak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: OPUS 19, Panel: NZ3

  42. 192. Atopic Dermatitis - searching for new strategic points of treatment, by evaluating clinical and prognostic significance …

    Principal investigator: Anna Maria Zaryczańska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: PRELUDIUM 19, Panel: NZ5

  43. 193. Immune response induced by injection-oral co-immunisation with plant-derived HBV antigens polarising the response to Th1…

    Principal investigator: prof. Tomasz Jan Pniewski

    Instytut Genetyki Roślin PAN

    Call: OPUS 19, Panel: NZ6

  44. 194. DNA polymerase θ as a novel therapeutic target in personalized anticancer therapy

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 19, Panel: NZ7

  45. 195. Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

    Principal investigator: Marek Andrzej Jamrozik

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  46. 196. Novel approach in the search for asthma and COPD therapies - computer aided design of multi-target-directed ligands bloc…

    Principal investigator: Alicja Aleksandra Gawalska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 19, Panel: NZ7

  47. 197. Application of small compounds in the epigenetic therapy of malignant brain gliomas

    Principal investigator: prof. Mirosława Zofia Naskręt-Barciszewska

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 19, Panel: NZ5

  48. 198. Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system…

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: SONATINA 4, Panel: NZ7

  49. 199. Investigation on PD-L1 biology for precise shaping of anticancer adoptive therapies

    Principal investigator: dr Agnieszka Graczyk-Jarzynka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: SONATA 15, Panel: NZ6

  50. 200. The 'omics' of renal cancer nucleolus: towards identification of new cancer markers and therapeutic targets.

    Principal investigator: prof. Agnieszka Piekiełko-Witkowska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO, Szkoła Nauk Medycznych

    Call: OPUS 18, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski